glp-1 digital health platforms startups The effect on MedTech What's next for GLP-1 innovation:

In parallel, we performed a CRISPR/Cas9 drop-out screen using a novel bovine genome-wide library in T

Review the management options available for carnitine deficiency

[11] Structure [edit] The GLP-1 receptor is a transmembrane protein composed of seven alpha-helical transmembrane domains (TM1-TM7), an extracellular N-terminus, and an intracellular C-terminus

New targeted therapies are being explored, including inhibitors specific for Kit-ligand, hepatocyte growth factor, or the MET signalling pathway

doi: 10.1016/S0140-6736(17)31472-1

Tesamorelin, a growth hormone-releasing factor analog, in HIV patients with abdominal fat accumulation (Phase 3)